Skip to main content
SINGULAR HEALTH GROUP LTD logo

SINGULAR HEALTH GROUP LTD — Investor Relations & Filings

Ticker · SHG ISIN · AU0000129892 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 364 across all filing types
Latest filing 2025-01-08 Share Issue/Capital Cha…
Country AU Australia
Listing ASX SHG

About SINGULAR HEALTH GROUP LTD

https://singular.health/

Singular Health Group Ltd specializes in the development and commercialization of medical imaging software designed to enhance personalized healthcare. The company’s primary offering, the 3Dicom software suite, employs proprietary volume rendering technology to transform standard 2D DICOM files, such as CT and MRI scans, into immersive 3D visualizations. This platform supports surgical planning, remote clinical collaboration, and patient education by providing interactive anatomical models. Singular Health integrates artificial intelligence to automate image segmentation and diagnostic workflows, facilitating more precise clinical outcomes. Through its 'Scan to Surgery' initiative, the company bridges the gap between diagnostic imaging and physical intervention using virtual reality and 3D printing. Its solutions target medical practitioners, dental professionals, and healthcare institutions globally.

Recent filings

Filing Released Lang Actions
Notification of cessation of securities - SHG 4 pages 15.0KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the cessation of certain securities (performance rights) for Singular Health Group Ltd. It includes specifics about the securities that have ceased, reasons for cessation, and updated issued capital figures. The document is an official announcement related to changes in the company's issued securities, specifically the expiry and removal of unvested performance rights. This type of announcement corresponds to a change in capital structure or securities status rather than a full financial report or management discussion. Given the nature of the content—notification of cessation of securities—and the format (Appendix 3H, a known ASX form for such notifications), the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length is 4452 characters, which is consistent with a detailed announcement rather than a brief notice or a full report. Therefore, the classification is SHA with high confidence.
2025-01-08 English
Application for quotation of securities - SHG 7 pages 21.9KB
Capital/Financing Update Classification · 100% confidence The document is an announcement from Singular Health Group Ltd dated December 31, 2024, detailing the quotation of securities issued due to options being exercised or convertible securities being converted. It includes specifics about the number and type of securities, issue dates, and whether the securities rank equally with existing ones. The document is structured as an official notification to the ASX (Australian Securities Exchange) regarding new securities to be quoted, referencing Appendix 2A of the ASX Listing Rules. There is no financial performance data, management discussion, or detailed financial statements. The content focuses on capital changes related to securities issuance and conversion. Therefore, this document fits the category of Capital/Financing Update (CAP).
2024-12-30 English
Exercise of Options and Cleansing Statement 1 page
Share Issue/Capital Change Classification · 95% confidence The document is a notice about the exercise of options and issuance of shares by Singular Health Group Limited. It includes details about the number of shares issued, the exercise price, and compliance with sections of the Corporations Act 2001. It also mentions an Appendix 2A for quotation of shares. The document is short (2450 characters) and primarily serves as an announcement of a share issuance event and related regulatory notice, rather than a detailed financial report or analysis. It does not contain financial statements or substantive financial data. Therefore, it fits best under the category of Share Issue/Capital Change (SHA).
2024-12-30 English
Engagement of Dr Ronny Low as Technical Advisor 3 pages 542.0KB
Board/Management Information Classification · 95% confidence The document is an announcement dated 23 December 2024 about the engagement of Dr Ronny Low as a Technical Advisor to Singular Health Group. It details his background, appointments, and the terms of his advisory role including options to be issued subject to shareholder approval. It also discusses proposed incentive options for the Managing Director and other directors. The content focuses on management changes and incentive arrangements rather than financial results, regulatory filings, or detailed financial reports. There is no indication of financial statements, earnings data, or regulatory certifications. The document is a corporate announcement about board/management appointments and incentive plans, fitting the Board/Management Information category (MANG). The document length (6349 characters) and content confirm it is not a brief announcement or a report publication notice but a substantive announcement of management changes and incentives.
2024-12-22 English
Investor Presentation - December 2024 16 pages 4.0MB
Investor Presentation Classification · 95% confidence The document is titled 'Investor Presentation December 2024' and contains detailed information about the company's business model, technology, market, management team, strategic partnerships, and financial snapshot. It includes forward-looking statements, disclaimers, and a comprehensive overview aimed at investors. There are no financial statements or regulatory filings, nor is it an announcement of a report or voting results. The content is consistent with a presentation designed to inform investors about the company's strategy, market position, and outlook. Therefore, the document fits the category of an Investor Presentation (IP). The document length (15,000 characters) and detailed content support this classification with high confidence.
2024-12-03 English
Application for quotation of securities - SHG 6 pages 18.7KB
Capital/Financing Update Classification · 100% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX. It details the number and type of securities to be quoted, issue dates, and references previous announcements (Appendix 3B) related to the securities issuance. The document is a formal announcement related to capital market activities, specifically the listing of new shares following a placement or issue. It does not contain financial statements, management discussion, or audit information. It is not a report but an official announcement of a capital market transaction. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is not a brief notice or a report publication announcement, but a substantive announcement about capital changes.
2024-11-27 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.